Geron | Capitale Ordinario



Ordinary Share Capital Cambiamento Data
Amgen USD 538M 33.04B 2025-06
Bio Techne USD 156.76M 155.19M 2025-06
Cassava Sciences USD 48K 0 2024-12
Cytokinetics USD 119.6M 119.48M 2025-06
Exelixis USD 270.13M 269.86M 2025-07
Genmab DKK 10M 56M 2025-03
Geron USD 636.92M 636.28M 2025-06
Gilead Sciences USD 1.24B 3M 2025-06
Incyte USD 194.12M 193.93M 2025-06
MacroGenics USD 628K 1000 2024-12
Novartis USD 793M 0 2024-12


Geron Capitale Ordinario - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.